Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse

Journal of Neuroimmunology

Volumn 85, Issue 2, 1998, Pages 122-130

  Gayo, Abel ^a   Mozo, Lourdes ^a   Suárez, Ana ^a   Tuñon, Alberto ^a   Lahoz, Carlos ^a   Gutiérrez, Carmen ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Glucocorticoids; Interleukin 10; Methylprednisolone; Multiple sclerosis

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ANTAGONIST; INTERLEUKIN 10; MESSENGER RNA; METHYLPREDNISOLONE; MIFEPRISTONE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; RECURRENCE; RNA, MESSENGER;

EID: 0032524790     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00262-2     Document Type: Article

References (30)

1. Arya S.K., Wong-Staal, Gallo R.C. Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon mRNA. J. Immunol. 133:1984;273-276.
2. Batuman O.A., Ferrero A., Cupp C., Jimenez S.A., Khalili K. Differential regulation of transforming growth factor β-1 gene expression by glucocorticoids in human T and Glial cells. J. Immunol. 155:1995;4397-4405.
3. Blotta M.H., Dekruyff R.H., Umetsu D.T. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158:1997;5589-5595.
4. Borish L., Aarons A., Rumbyrt J., Cvietusa P.J., Wenzel S. Interleukin 10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97:1996;1288-1296.
5. Boumpas D.T., Anastassiou E.D., Older S.A., Tsokos G.C., Nelson D.L., Balow J.E. Dexamethasone inhibits human IL-2 but not IL-2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1991;1739-1747.
6. Chernoff A.E., Granowitz E.V., Shapiro L., Vannier E., Lonnemann G., Angel J.B., Kennedy S.J., Rabson A.R., Wolff S.M., Dinarello C.A. A randomized, controlled trial of IL-10 in humans. J. Immunol. 154:1995;5492-5499.
7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
8. De Waal Malefyt R., Abrams J., Bennet B., Figdor C.G., de Vries J.E. Interleukin 10 inhibits cytokine synthesis by human monosytes: an autoregulatory role of IL.10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
9. Del Prete G., De Carli M., Almerigogna F., Giudizi M.G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:1993;353-360.
10. Guillaland G., Perrin S., Blanchard K., Bunn H.F. Analysis of cytokine mRNA and DNA. Detection and quantitation by competitive polymerase. Proc. Natl. Acad. Sci. U.S.A. 87:1990;2725-2729.
11. Han J., Thompson, Beutler B. Dexamethasone and pentoxifilline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J. Exp. Med. 172:1990;391.
12. Kennedy M.K., Torrance D.S., Picha K.S., Mohler K.M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental allergic encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:1992;2469-2505.
13. Kube D., Platzer C., Von Kenethen A., Straub H., Bohlen H., Hafner M., Tesch H. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine. 7.1:1995;1-7.
14. Kupersmith M.J., Kaufman D., Paty D.W., Ebers G., Mc Farland H., Johnson K., Reingold S., Whitaker J. Megadose corticosteroids in multiple sclerosis. Neurology. 44:1994;1-4.
15. Mussette P., Benveniste O., Lim A., Bequet D., Kourilsky P., Dormont D., Gachelim G. The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis. Res. Immunol. 147:1996;435-445.
16. Navikas V., Link J., Palasik W., Söderström M., Fredrikson S., Olsson T., Link Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand. J. Immunol. 41:1995;171-178.
17. North M.E., Ivory K., Funauchi M., Webster A.D.B., Lane A.C., Farrant J. Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin. Exp. Immunol. 105:1996;517-522.
18. Olsson T. Immunology of multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 5:1992;195-202.
19. Platzer C., Meisel Ch., Vogt M., Volk H.D. Up-regulation of monocytic IL-10 tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7(4):1995;517-523.
20. Poser C.M., Paty D.W., Sheinberg L.et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1990;227-231.
21. Raeymaekers L. Quantitative PCR. Theoretical considerations with practical implications. Anal. Biochem. 214:1993;582-585.
22. Ramirez F., Fowell D.J., Puklavec M., Simmonds S., Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156:1996;2406-2412.
23. Rieckmann P., Albrecht M., Kitze B., Weber T., Poser Cytokine mRNA levels in mononuclear cells from patients with multiple sclerosis. Neurology. 44:1994;1523-1526.
24. Rieckmann P., Albrecht M., Kitze B., Weber T., Poser Tumor necrosis factor alpha messenger RNA expression in patients with relapsing-remitting MS is associated with disease activity. Ann. Neurol. 37:1995;82-87.
25. Selmaj K., Raine C., Canella B., Brosnan C.F. Identification of lymphotoxin and TNF in multiple sclerosis lesion. J. Clin. Invest. 87:1991;949-954.
26. Sharief M.K., Hentges R. Association between TNF-α and disease progression in patients with multiple sclerosis. New Engl. J. Med. 325:1991;467-472.
27. Tabardel Y., Duchateu J., Schamartz D., Marécaux G., Shahla M., Barvais L., Lecler J.L., Vincent J.L. Corticosteroids increase blood interleukin 10 levels during cardiopulmonary bypass in men. Surgery. 119:1996;76-80.
28. Van der Poll T., Barber A.E., Coyle S.M., Lowry S.F. Hypercortisolemia increased plasma interleukin-10. Concentration during human endotoxemia. A clinical research center study. J. Clin. Endocrinol. Metabol. 81:1996;3604-3606.
29. Wang P., Wu P., Siegel M.I., Egan R.V., Motasim B. Il-10 inhibits transcription of cytokine genes in human peripheral mononuclear cells. J. Immunol. 153:1994;811-816.
30. Wanidworanun W., Strober W. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J. Immunol. 151:1993;6853-6861.